Drug intelligence / Profile preview

Bronchitol

Development stage
Approved
Lead developer
Pharmaxis
Modality
Inhalation Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules
Administration
Inhalation
01

Overview

Bronchitol is a dry powder formulation of mannitol for oral inhalation. It is indicated as an add-on maintenance therapy to improve pulmonary function in adults 18 years and older with cystic fibrosis who have passed the Bronchitol Tolerance Test. Mannitol acts as an osmotic agent in the airways; when inhaled, it draws water into the airway lumen, hydrating and thinning mucus to facilitate its clearance from the lungs. This mechanism helps improve lung function by making it easier for patients with cystic fibrosis to expectorate thick mucus[1][2][4][5][8]. The drug should not be used in children or adolescents under 18 years old due to insufficient safety and efficacy data[2][3]. The most common side effects include cough, hemoptysis (coughing up blood), throat irritation or pain, vomiting, fever, joint pain, and bacterial presence in sputum[2][3][7].

Brand names
Bronchitol
Other names
mannitol inhalation powdermannitol (inhaled)INN-mannitolD-mannitol(L)-mannitol

Beyond the preview

Go deeper on Bronchitol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchitol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call